PharmaRoth Labs(OTC) ROTH

PharmaRoth Labs, Inc. is a nutraceutical company focused on producing and distributing Sucanon, an herbal-based treatment for type-2 diabetes. Established in 2000 and based in Las Vegas, Nevada, the company aims to improve health outcomes through innovative products.

Products and Services

• Sucanon: An herbal-based nutraceutical for type-2 diabetes management
• Research and development of additional health-focused products
• Marketing and distribution services for nutraceuticals

Growth Outlook

• Market demand for diabetes management solutions is increasing
• Expansion into new markets is planned to enhance reach
• Focus on product innovation to capture consumer interest

Financial Highlights

• Recent quarterly net income reported at -$22,455
• Trailing twelve months (TTM) revenue of $0.00001 per share
• Current ratio at 0.35 indicates liquidity challenges

PharmaRoth Labs, Inc. operates in the healthcare sector, specifically within the medical pharmaceuticals industry. The company has positioned itself to address the growing need for effective diabetes management solutions through its flagship product, Sucanon. With a focus on research and development, PharmaRoth Labs aims to expand its product offerings and market presence. The growth outlook for PharmaRoth Labs is promising, driven by increasing market demand for diabetes-related health products. The company plans to explore new markets and innovate its product line to attract a broader consumer base. This strategic direction is essential for capturing market share in a competitive landscape. Financially, the company has faced challenges, as indicated by the recent quarterly net income loss. However, the revenue per share remains a focal point for potential recovery. The current ratio suggests liquidity issues, which may impact operational flexibility. Investors may find the company's commitment to innovation and market expansion noteworthy as it navigates these financial hurdles.